patent/EP-1172654-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1172654-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7291cb2057e396f6275672b31837e51d
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57442
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
filingDate	2000-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f977b15c9e9adcaf000df5a25566ae9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc1270e4fed968407cec1b1d815db7b5
publicationDate	2002-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-1172654-A1
titleOfInvention	Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors
abstract	A method is described for the diagnosis of an ovarian ornendometrial tumor or for a prognosis, characterized in thatnthe L1 level is determined in a patient sample, preferablynvia an anti L1 antibody, the presence of L1 being annindication of the presence of an ovarian or endometrialntumor or a predisposition for such a tumor.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101504039-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8138313-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008151819-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2631248-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010062143-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8153122-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2631248-A3
priorityDate	2000-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394213 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555088 http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57105 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4640 http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57105

Total number of triples: 43.